Synthesis of heteroaryl/aryl kojic acid conjugates as stimulators of glucose uptake by GLUT4 translocation
摘要:
Insulin exerts its metabolic actions through the insulin receptor (IR) and plays an essential role in treatment of diabetes. The inconvenience of daily injections and the undesirable side-effects associated with insulin injections demand novel drugs for the disease. To search for bioactive insulin mimetic, we synthesized a chemical library of small molecules (2a-3f) based on the indolylkojic acid scaffold (B). An In vitro screening assay was performed to stimulate glucose transport in rat L6 skeletal muscle cells, post treatment of the compounds (2a-3f) for the time period incubation of 16 h. Compounds 2f, 2g, 21, 3a, 3b, 3c and 3d have shown significant glucose uptake stimulation as compared to the controls at micromolar concentrations. In mechanistic studies, we observed that these compounds exert their biological action by enhancing GLUT4 translocation to cell surface via PI3K-dependent signalling pathway in agreement to the insulin mode of action. Hence, these promising conjugates should be useful for further drug development in diabetes treatment. (C) 2014 Elsevier Masson SAS. All rights reserved.
Microwave-Assisted Condensation of Kojic Acid with Aldehydes
作者:Pan-Pan Hu、Chun-Feng Zhu、Tao Zhou
DOI:10.3184/174751912x13383100102119
日期:2012.8
Kojicacid derivatives have been prepared in excellent yield by the condensation of two molecules of kojicacid and one molecule of an aldehyde using sodium carbonate as a base under microwave irradiation.
通过使用碳酸钠作为碱在微波辐射下将两分子曲酸和一分子醛缩合,已经以优异的产率制备曲酸衍生物。
DRUG FOR AMELIORATING BRAIN DISEASES
申请人:WAKUNAGA PHARMACEUTICAL CO., LTD.
公开号:EP0838220A1
公开(公告)日:1998-04-29
The present invention discloses a drug for ameliorating brain diseases which comprises as an active ingredient a compound represented by the following formula (1):
[wherein R1 represents H, OH, a lower alkoxyl group, or a lower alkyl group; each of R2 and R3 represents H, a (substituted) lower alkyl group, a lower alkenyl group, a (substituted) phenyl group, or a (substituted) styryl group; and X represents O or a nitrogen atom which may be substituted by a lower alkyl group] or a salt thereof. Because of inhibiting a decrease in brain neurons and promoting branching of neurites, this drug is efficacious in the prevention and treatment of dementia, etc. in association with degeneration and sloughing of brain neurons.
Synthesis of heteroaryl/aryl kojic acid conjugates as stimulators of glucose uptake by GLUT4 translocation
作者:Deepak K. Sharma、Jyotsana Pandey、Akhilesh K. Tamrakar、Debaraj Mukherjee
DOI:10.1016/j.ejmech.2014.08.041
日期:2014.10
Insulin exerts its metabolic actions through the insulin receptor (IR) and plays an essential role in treatment of diabetes. The inconvenience of daily injections and the undesirable side-effects associated with insulin injections demand novel drugs for the disease. To search for bioactive insulin mimetic, we synthesized a chemical library of small molecules (2a-3f) based on the indolylkojic acid scaffold (B). An In vitro screening assay was performed to stimulate glucose transport in rat L6 skeletal muscle cells, post treatment of the compounds (2a-3f) for the time period incubation of 16 h. Compounds 2f, 2g, 21, 3a, 3b, 3c and 3d have shown significant glucose uptake stimulation as compared to the controls at micromolar concentrations. In mechanistic studies, we observed that these compounds exert their biological action by enhancing GLUT4 translocation to cell surface via PI3K-dependent signalling pathway in agreement to the insulin mode of action. Hence, these promising conjugates should be useful for further drug development in diabetes treatment. (C) 2014 Elsevier Masson SAS. All rights reserved.
Aldol reaction of kojic acid using alumina supported base catalyst and enzymatic resolution of the aldol adduct by CALB
作者:Deepak K. Sharma、Baldev Singh、Debaraj Mukherjee
DOI:10.1016/j.tetlet.2014.08.113
日期:2014.10
An efficient and ecofriendly aldol reaction of kojic acid with aldehydes using a heterogeneous reusable catalyst (alumina modified with base) is developed. Enzymatic hydrolytic resolution of the racemic acetylated aldol adduct 2 was achieved using lipase from Candida antarctica type B (CALB). The key feature of this enzymaticresolution is that regioselective deacetylation of ester derived from the